Your session is about to expire
← Back to Search
Rhythm-Based Therapy for Aphasia
N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not suffer from any other type of neurological disease.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to explore the effectiveness of a music-based therapy called melodic intonation therapy (MIT) for people with aphasia, a language disorder that affects communication. The first goal is to determine
Who is the study for?
This trial is for individuals who have aphasia, a language disorder, after experiencing a stroke at least six months ago. Participants should be able to move their left side and name some items but must not have other neurological diseases.
What is being tested?
The study tests a rhythm-based speech therapy app called Speech Hero. It aims to improve speech fluency in people with aphasia by using rhythmic patterns through an engaging video game platform.
What are the potential side effects?
Since the intervention involves non-invasive therapy using an app, there are no direct physical side effects expected from this treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have any neurological diseases.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Aphasia spoken word assessment
Western Aphasia Battery (WAB) test
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Rhythm interventionExperimental Treatment1 Intervention
Group II: Non-rhythm interventionActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,719 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
182,038 Total Patients Enrolled
The University of Texas at DallasLead Sponsor
67 Previous Clinical Trials
108,087 Total Patients Enrolled